ARTiFACTS provides a platform for pharmaceutical quality verification using destructive testing and advanced chemical analysis. Its Verify system detects substandard and falsified medicines, generating actionable intelligence on supply chain risks for manufacturers, distributors, and healthcare providers.
Funding
Funding not disclosed
Founders
Product
Problem
Substandard and falsified medicines pose a significant risk to patient safety and public health, undermining trust in the global drug supply chain. Existing monitoring systems often lack the granular, chemical-level data required to accurately identify and mitigate these threats.
Solution
ARTiFACTS offers a comprehensive platform for analyzing and verifying the quality and safety of pharmaceuticals throughout the global supply chain. The core Verify system employs destructive testing and advanced chemical analysis to detect substandard and falsified medicines. This process generates actionable intelligence on medicine quality risks, enabling stakeholders to implement informed mitigation strategies. The platform provides detailed reports and analytics accessible via web browsers and mobile devices, offering insights into current and historical results, emerging hotspots of quality issues, and predictive indicators of future risks.
Target Audience
ARTiFACTS serves pharmaceutical manufacturers, distributors, regulatory agencies, and healthcare providers who are responsible for ensuring the quality and safety of medicines within their supply chains.
Features
- Destructive testing and chemical analysis of pharmaceuticals to identify substandard and falsified products.
- Coverage for approximately 300 commonly prescribed medicines, including a significant portion of WHO Essential Medicines, with ongoing expansion.
- Data collection and reporting capabilities encompassing medicine location, protocol requirements, primary data, chemical screen results, and handling procedures.
- Web and mobile accessibility for reports and analytics, providing insights into medicine quality risks.
- API integration for accessing current and historical results, filterable by location, lot number, and manufacturer.
- Identification of emerging quality risk hotspots and trends to inform proactive mitigation actions.
- Support for various stakeholders including pharmacy managers, clinicians, purchasers, distributors, manufacturers, and regulatory agencies.